TD Cowen reiterates Senseonics stock rating on growth drivers
TD Cowen reiterated a Buy rating and $15.00 price target for Senseonics Holdings (SENS), citing growth drivers like U.S. direct-to-consumer conversions and Europe rebound. The stock is up 73% YTD. Q2 2026 revenue surged 120% YoY to $14.5M, beating estimates, but loss per share widened slightly. Gross margin is 55%, with analysts expecting continued sales growth.
How this was made
The 30-second read
Why it matters
The analyst upgrade provides a fresh catalyst but rests on already‑public earnings, limiting trading impact.
Market read
Recap of earnings with a new rating; modest relevance for short‑term traders.
What to watch
Potential competitive pressure from larger CGM players.
Background
The article repeats Senseonics' Q2 2026 earnings that were released 46 days earlier and adds an analyst rating upgrade.
Ticker impact
TD Cowen reiterated a Buy rating and $15 price target for Senseonics, citing growth drivers and Q2 earnings figures.
modest upside if investors follow the new target
Rating and target are new analyst actions, but they rest on already‑published earnings data.
Market effects
Limited; reinforces positive view of diabetes‑monitoring devices.
None
Low
Counterpoint
The rating may be premature given the widening loss per share.
Key entities
- CompanySenseonics Holdings
Medical device maker of continuous glucose monitors.
- Research FirmTD Cowen
Equity research analyst firm issuing the rating.
